Romidepsin Exhibits Anti-Esophageal Squamous Cell Carcinoma Activity Through the DDIT4-mTORC1 Pathway

Medicine, Medical Laboratory Science, Oncology, Life Sciences, Cell Biology, Biochemistry,
Romidepsin   Esophageal Squamous Cell Carcinoma   DDIT4   mTORC1   Drug Screening   Apoptosis   Cell Cycle Arrest  

Romidepsin Exhibits Anti-Esophageal Squamous Cell Carcinoma Activity through DDIT4-mTORC1 Pathway Esophageal squamous cell carcinoma (ESCC) is one of the most common human malignancies globally, with high incidence and mortality rates. Given the limited current treatment options, there is an urgent need to develop new effective therapeutic drugs. I...